Profilo
Ehud Shoshani served as the Chief Executive Officer at Quintiles UK Ltd.
and as the Medical Director at OMRIX Biopharmaceuticals, Inc. and Gamida Cell Ltd.
He also worked as the Vice President-Clinical Affairs at Aevi Genomic Medicine, Inc. Shoshani holds a doctorate degree from Technion-Israel Institute of Technology, which he received in 1978.
Precedenti posizioni note di Ehud Shoshani
| Società | Posizione | Fine |
|---|---|---|
| GAMIDA CELL LTD. | Direttore Tecnico/Scientifico/R&S | - |
| Quintiles UK Ltd. | Presidente | - |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Direttore Tecnico/Scientifico/R&S | - |
| AEVI GENOMIC MEDICINE, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Ehud Shoshani
| Technion-Israel Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
| Quintiles UK Ltd. | |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
- Borsa valori
- Insiders
- Ehud Shoshani
